Riskpilot← Back to searchSign inGet full accessDr. Danson Holding ApS
APSActiveCVR 38728903Sandbyvej 42Activities of holding companies · NACE 6421Est. 2017— employees
Revenue 2025
DKK -295K
+137% vs 2024
EBITDA margin
100.0%
-137% vs 2024
Equity ratio
57.6%
Financial strength
Net profit 2025
DKK 6,2M
+122% vs 2024
| Revenue | DKK -295K | +137% |
| EBITDA | DKK -295K | -137% |
| Net profit | DKK 6,2M | +122% |
| Total assets | DKK 23,3M | +102% |
| Equity | DKK 13,4M | +29% |
| Employees | — | — |
Legal name
Dr. Danson Holding ApS
CVR number
38728903
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
10. juni 2017
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af direktøren
Company purpose
Virksomhedens formål er at eje anparter i andre selskaber, samt efter ledelsens skøn hermed beslægtet virksomhed.
Address
Sandbyvej 42
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | -89 | -92 | -79 | -124 | -295 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -89 | -92 | -79 | -124 | -295 |
| Depreciation & amort. | -22 | -25 | -78 | -83 | -167 |
| EBIT | -111 | -117 | -156 | -207 | -462 |
| Net financials | 955 | 2.543 | 2.898 | 2.944 | 6.542 |
| Profit before tax | 844 | 2.426 | 2.741 | 2.737 | 6.080 |
| Tax | -43 | -27 | -32 | -40 | -90 |
| Net profit | 887 | 2.453 | 2.773 | 2.777 | 6.170 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4.899 | 7.027 | 11.220 | 11.504 | 23.286 |
| Equity | 3.615 | 5.018 | 7.733 | 10.388 | 13.423 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.284 | 2.008 | 3.487 | 1.116 | 9.864 |
| Total debt | 1.284 | 2.008 | 3.487 | 1.116 | 9.864 |
EBITDA margin
-29487400.0%
This company
15.8%
Market median
-186629214% vs market
20212025
Equity ratio
57.6%
This company
38.2%
Market median
+51% vs market
20212025
Return on equity
46.0%
This company
18.4%
Market median
+150% vs market
20212025
Net profit margin
616971500.0%
This company
8.1%
Market median
+7616931999% vs market
20212025
Asset turnover
-0.01×
This company
1.12×
Market median
-101% vs market
20212025
Debt / equity
0.73×
This company
0.62×
Market median
+18% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 66.67–89.99% | 100% | 2025 | |
| Individual | 10–14.99% | 0% | 2025 | |
| Individual | 10–14.99% | 0% | 2025 | |
| Individual | 10–14.99% | 0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Dr. Danson Holding ApS (this company)
Bright Sight Holding ApSBoard members of Dr. Danson Holding ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|